Spots Global Cancer Trial Database for tobemstomig
Every month we try and update this database with for tobemstomig cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study of Lomvastomig (RO7121661) and Tobemstomig (RO7247669) Compared With Nivolumab in Participants With Advanced or Metastatic Squamous Cell Carcinoma of the Esophagus | NCT04785820 | Advanced or Met... | Lomvastomig Tobemstomig Nivolumab | 18 Years - | Hoffmann-La Roche | |
| A Study of Tobemstomig Plus Platinum-Based Chemotherapy vs Pembrolizumab Plus Platinum-Based Chemotherapy in Participants With Previously Untreated Non-Small Cell Lung Cancer | NCT05775289 | Non-small Cell ... | Tobemstomig Pembrolizumab Paclitaxel Pemetrexed Carboplatin | 18 Years - | Hoffmann-La Roche | |
| A Study Evaluating The Efficacy and Safety of Neoadjuvant Immunotherapy Combinations in Patients With Surgically Resectable Hepatocellular Carcinoma | NCT05908786 | Carcinoma, Hepa... | Atezolizumab Bevacizumab Tiragolumab Tobemstomig | 18 Years - | Hoffmann-La Roche | |
| A Study of Tobemstomig + Nab-Paclitaxel Compared With Pembrolizumab + Nab-Paclitaxel in Participants With Previously Untreated, PD-L1-Positive, Locally-Advanced Unresectable or Metastatic Triple-Negative Breast Cancer | NCT05852691 | Breast Cancer | Tobemstomig Pembrolizumab Nab-Paclitaxel | 18 Years - | Hoffmann-La Roche | |
| A Study of Immune Checkpoint Inhibitor Combinations With Axitinib in Participants With Untreated Locally Advanced Unresectable or Metastatic Renal Cell Carcinoma | NCT05805501 | Renal Cell Carc... | Tobemstomig Tiragolumab Pembrolizumab Axitinib | 18 Years - | Hoffmann-La Roche | |
| A Study Evaluating Different Immunotherapies (LAG-3 and PD-1 With or Without TIGIT, Compared to PD-L1 Alone) in Participants With Untreated Locally Advanced Metastatic Urothelial Cancer | NCT05645692 | Urothelial Canc... | Atezolizumab Tobemstomig Tiragolumab | 18 Years - | Hoffmann-La Roche | |
| A Study Evaluating The Efficacy and Safety of Neoadjuvant Immunotherapy Combinations in Patients With Surgically Resectable Hepatocellular Carcinoma | NCT05908786 | Carcinoma, Hepa... | Atezolizumab Bevacizumab Tiragolumab Tobemstomig | 18 Years - | Hoffmann-La Roche | |
| A Study of Tobemstomig Plus Platinum-Based Chemotherapy vs Pembrolizumab Plus Platinum-Based Chemotherapy in Participants With Previously Untreated Non-Small Cell Lung Cancer | NCT05775289 | Non-small Cell ... | Tobemstomig Pembrolizumab Paclitaxel Pemetrexed Carboplatin | 18 Years - | Hoffmann-La Roche | |
| A Study Evaluating Different Immunotherapies (LAG-3 and PD-1 With or Without TIGIT, Compared to PD-L1 Alone) in Participants With Untreated Locally Advanced Metastatic Urothelial Cancer | NCT05645692 | Urothelial Canc... | Atezolizumab Tobemstomig Tiragolumab | 18 Years - | Hoffmann-La Roche | |
| A Study of Immune Checkpoint Inhibitor Combinations With Axitinib in Participants With Untreated Locally Advanced Unresectable or Metastatic Renal Cell Carcinoma | NCT05805501 | Renal Cell Carc... | Tobemstomig Tiragolumab Pembrolizumab Axitinib | 18 Years - | Hoffmann-La Roche | |
| A Study of Immune Checkpoint Inhibitor Combinations With Axitinib in Participants With Untreated Locally Advanced Unresectable or Metastatic Renal Cell Carcinoma | NCT05805501 | Renal Cell Carc... | Tobemstomig Tiragolumab Pembrolizumab Axitinib | 18 Years - | Hoffmann-La Roche | |
| A Study of Immune Checkpoint Inhibitor Combinations With Axitinib in Participants With Untreated Locally Advanced Unresectable or Metastatic Renal Cell Carcinoma | NCT05805501 | Renal Cell Carc... | Tobemstomig Tiragolumab Pembrolizumab Axitinib | 18 Years - | Hoffmann-La Roche |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
